Online Training After Cancer (On-Trac): Developing An Online Intervention for Cancer Survivors Managing Anxiety
Dana-Farber Cancer Institute
Summary
This study is evaluating On-Trac (Online Training After Cancer), an online educational intervention to teach adult cancer survivors strategies to address anxiety based on Cognitive-Behavioral Therapy (CBT) and Acceptance Commitment Therapy (ACT) The name of the study intervention is Online Training After Cancer (On-Trac)
Description
This is a minimal-risk behavioral optimization trial to optimize and refine On-Trac (Online Training After Cancer), an online educational intervention designed to help adult cancer survivors. The research study procedures include screening for eligibility, questionnaires and interviews. Participation in the study involves: * Completing online survey using using a web-based survey platform for baseline assessment * Taking part in an online, 120 minute, group session via video conference platform and completing an online questionnaire. * Completing 1-2, 30-40 minute, individual coaching sessi…
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Age ≥ 18 * A diagnosis of cancer (except non-melanoma skin cancer) ≥ 12 months prior. * No active cancer therapy (excluding chemoprevention) in the past 4 months, and no further therapy planned. * Significant anxiety as evidenced by both of the following * Endorsement of the SCID ( Structured Clinical Interview for the DSM-5) Screener Items for Social Anxiety Disorder, Generalized Anxiety Disorder, Agoraphobia, Specific Phobia, or Illness Anxiety Disorder. * A score ≥ 6 on the Overall Anxiety Severity and Impairment Scale (OASIS). * Regular access to the internet. *…
Interventions
- BehavioralON-TRAC Education session
120 minute educational session on strategies for anxiety delivered via synchronous videoconference session
- BehavioralON-TRAC Coaching
30-40 minute individual coaching sessions on implementation of strategies for anxiety
Location
- Dana Farber Cancer InstituteBoston, Massachusetts